Gene, Cell and Tissue

Published by: Kowsar

The Role of RNASEL Mutation in the Complex Genetic Landscape of Prostate Adenocarcinoma

Michael Karsy 1 , *
Author Information
1 Department of Neurosurgery, University of Utah, Salt Lake City, USA
Article information
  • Gene, Cell and Tissue: November 01, 2014, 1 (3); e23703
  • Published Online: October 29, 2014
  • Article Type: Letter
  • Received: September 17, 2014
  • Accepted: September 30, 2014
  • DOI: 10.17795/gct-23703

To Cite: Karsy M. The Role of RNASEL Mutation in the Complex Genetic Landscape of Prostate Adenocarcinoma, Gene Cell Tissue. 2014 ; 1(3):e23703. doi: 10.17795/gct-23703.

Copyright © 2014, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Acknowledgements
References
  • 1. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; 64(4): 252-71[DOI][PubMed]
  • 2. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science. 1996; 274(5291): 1371-4[PubMed]
  • 3. Ostrander EA, Stanford JL. Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet. 2000; 67(6): 1367-75[DOI][PubMed]
  • 4. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet. 2002; 30(2): 181-4[DOI][PubMed]
  • 5. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet. 2002; 32(4): 581-3[DOI][PubMed]
  • 6. Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum Mol Genet. 2004; 13 Spec No 1-21[DOI][PubMed]
  • 7. Van den Broeck T, Joniau S, Clinckemalie L, Helsen C, Prekovic S, Spans L, et al. The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making. Biomed Res Int. 2014; 2014: 627510[DOI][PubMed]
  • 8. Seidabadi A, Rezatofighi SE, Motamedi H, Rashidi I. R462Q Mutation in Prostate Cancer Specimens. Gene Cell Tissue. 2014; 1(2)
  • 9. Shea PR, Ishwad CS, Bunker CH, Patrick AL, Kuller LH, Ferrell RE. RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans. Prostate. 2008; 68(4): 354-9[DOI][PubMed]
  • 10. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet. 2014; 46(10): 1103-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments